Similar articles

• Applications of monoclonal antibodies in the diagnosis and treatment of primary brain tumors.

  Bullard DE, Bigner DD. Bullard DE, et al. J Neurosurg. 1985 Jul;63(1):2-16. doi: 10.3171/jns.1985.63.1.0002. J Neurosurg. 1985. PMID: 2409248 Review.
• Glioma proteomics: status and perspectives.

  Niclou SP, Fack F, Rajcevic U. Niclou SP, et al. J Proteomics. 2010 Sep 10;73(10):1823-38. doi: 10.1016/j.jprot.2010.03.007. Epub 2010 Mar 20. J Proteomics. 2010. PMID: 20332038 Review.
• Tumor markers: malignin and related recognins associated with malignancy rather than with cell type.

  Bogoch S, Bogoch ES. Bogoch S, et al. Prog Clin Biol Res. 1980;39:407-24. Prog Clin Biol Res. 1980. PMID: 7403189 No abstract available.
• Characterization of neuroectodermal antigen by a monoclonal antibody and its application in CSF diagnosis of human glioma.

  Wakabayashi T, Yoshida J, Seo H, Kazo K, Murata Y, Matsui N, Kageyama N. Wakabayashi T, et al. J Neurosurg. 1988 Mar;68(3):449-55. doi: 10.3171/jns.1988.68.3.0449. J Neurosurg. 1988. PMID: 3343615
• Human glioma associated and related antigens, identified by monoclonal antibodies.

  Yoshida J, Kageyama N, Ueda R, Takahashi T. Yoshida J, et al. Neurosurg Rev. 1984;7(1):23-8. doi: 10.1007/BF01743287. Neurosurg Rev. 1984. PMID: 6205324